Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-034818

Chairman and CEO bought 168 shares at an average $4.80 ($807)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KAZIMI A J Chairman and CEO 2025-06-02 Purchase 10b5-1 +8 $5.20 $42 5,699,268 D
KAZIMI A J Chairman and CEO 2025-06-03 Purchase 10b5-1 +8 $5.61 $45 5,699,276 D
KAZIMI A J Chairman and CEO 2025-06-04 Purchase 10b5-1 +8 $5.75 $46 5,699,284 D
KAZIMI A J Chairman and CEO 2025-06-05 Purchase 10b5-1 +8 $5.46 $44 5,699,292 D
KAZIMI A J Chairman and CEO 2025-06-06 Purchase 10b5-1 +8 $5.57 $45 5,699,300 D
KAZIMI A J Chairman and CEO 2025-06-09 Purchase 10b5-1 +8 $5.94 $48 5,699,308 D
KAZIMI A J Chairman and CEO 2025-06-10 Purchase 10b5-1 +8 $6.00 $48 5,699,316 D
KAZIMI A J Chairman and CEO 2025-06-11 Purchase 10b5-1 +8 $5.57 $45 5,699,324 D
KAZIMI A J Chairman and CEO 2025-06-12 Purchase 10b5-1 +8 $5.67 $45 5,699,332 D
KAZIMI A J Chairman and CEO 2025-06-13 Purchase 10b5-1 +8 $5.81 $46 5,699,340 D
KAZIMI A J Chairman and CEO 2025-06-16 Purchase 10b5-1 +8 $5.32 $43 5,699,348 D
KAZIMI A J Chairman and CEO 2025-06-17 Purchase 10b5-1 +8 $5.61 $45 5,699,356 D
KAZIMI A J Chairman and CEO 2025-06-18 Purchase 10b5-1 +8 $5.52 $44 5,699,364 D
KAZIMI A J Chairman and CEO 2025-06-20 Purchase 10b5-1 +8 $5.29 $42 5,699,372 D
KAZIMI A J Chairman and CEO 2025-06-23 Purchase 10b5-1 +8 $4.61 $37 5,699,380 D
KAZIMI A J Chairman and CEO 2025-06-24 Purchase 10b5-1 +8 $3.91 $31 5,699,388 D
KAZIMI A J Chairman and CEO 2025-06-25 Purchase 10b5-1 +8 $3.27 $26 5,699,396 D
KAZIMI A J Chairman and CEO 2025-06-26 Purchase 10b5-1 +8 $2.71 $22 5,699,404 D
KAZIMI A J Chairman and CEO 2025-06-27 Purchase 10b5-1 +8 $2.60 $21 5,699,412 D
KAZIMI A J Chairman and CEO 2025-06-30 Purchase 10b5-1 +16 $2.74 $44 5,699,428 D
Open-market purchases · 168 sh · avg $4.80 · $807
Loading xslF345X05/wk-form4_1752270582.xml…